Navigation Links
Prescient Medical Inc. Featured on FOX Business Network
Date:8/27/2009

DOYLESTOWN, Pa., Aug. 27 /PRNewswire/ -- Prescient Medical Inc. announced that CEO Patricia Scheller, appeared on FOX Business Network (FBN) to discuss the company's groundbreaking products and recent achievement of CE Mark approval for their vProtect(TM) Luminal Shield Stent System.

"The FOX Business News appearance is an important recognition of the increasing awareness of cardiovascular disease," stated Ms. Scheller. Each year, approximately 1.5 million Americans will have a heart attack and 650,000 will not survive, making it the leading cause of death in the US. It is estimated that the costs associated with treating heart attacks in the US are over $80 billion per year, or approximately $54,000 per patient, according to 2007 statistics. In addition to the significant financial expenses, the societal and personal costs of the disease are also substantial. "Our goal at Prescient is to ultimately provide the world's first products to stop heart attacks before they happen," she continued.

Ms. Scheller was featured on the "C-Suite Sit-Down" segment on Monday, August 24, 2009, broadcast at 6:40 AM (EDT) in the United States.

Prescient Medical was founded to commercialize a pioneering suite of diagnostic technologies and protective solutions for people with cardiovascular disease. The Company's mission is to reduce morbidity and mortality from heart attacks. Prescient's product portfolio includes catheter-based devices that will allow interventional cardiologists to more precisely tailor focal treatment according to the unique needs of each patient.

The full interview is available through the following link: http://video.foxbusiness.com/8606056/preventative-care-for-heart-attacks/?category_id=e58d253d419a3e2328d5a7b6055c6313acb46bf6.

About FOX Business Network

FOX Business Network (FBN) is a financial news channel delivering real-time information across all platforms that impact both Main Street and Wall Street. FBN is headquartered in New York, the business capital of the world. Launched in October 2007, the Network is available in more than 35 million homes in major markets across the United States. Owned by News Corp., the Network has bureaus in Chicago, Los Angeles, Silicon Valley, Washington, DC and London (www.foxbusiness.com).

About Prescient Medical

Prescient Medical, Inc. is a privately-held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The Company is the recipient of the 2009 Frost and Sullivan Award for Product Innovation of the Year Award for vProtect(TM) Luminal Shield. For more information, please visit our website at www.prescientmedical.com.


'/>"/>
SOURCE Prescient Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Momentum Women(TM) Honors Patricia Scheller of Prescient Medical for Commitment to Promoting Cardiovascular Disease Awareness
2. Prescient Medical Receives Frost & Sullivan Product Innovation of the Year Award
3. vProtect Luminal Shield (TM) from Prescient Medical Receives CE Mark
4. MSU engineering team designs innovative medical device
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
7. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
8. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
9. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
10. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
11. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... ... ... Millions of families and businesses worldwide depend on high quality water from ... water. However, well water can also become contaminated with bacteria and odors from flood ... The EPA does not regulate private drinking water wells. Many states and towns do ...
(Date:9/24/2017)... ... ... boy was walking home and feeling down about himself. He didn’t think he was good ... he can do whatever he wants to do if he puts his mind to it. ... God created him with special talents and gifts. We see his internal dialogue change. He ...
(Date:9/24/2017)... ... ... The Other Sheep”: the ceremonial laws of Moses and the Holy Law of God reexamined. ... author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, but he ... Adventist Church for many years. He was previously a member of the Anglican Church ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... Albert Lea, MN (PRWEB) , ... September 22, 2017 , ... ... and video) at its rally to interview citizens on why they are rallying against ... stories and commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: